The risk or severity of adverse effects can be increased when Tranilast is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Vinpocetine is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Aluminium. The risk or severity of adverse effects can be increased when Progesterone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ziprasidone is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Imidapril. The serum concentration of Atorvastatin can be decreased when it is combined with Bexarotene. The risk or severity of adverse effects can be increased when Nifedipine is combined with Atorvastatin. The serum concentration of Dabigatran etexilate can be decreased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Nitroaspirin. The serum concentration of Atorvastatin can be increased when it is combined with Nelfinavir. The serum concentration of Atorvastatin can be decreased when it is combined with Mitotane. The metabolism of Atorvastatin can be decreased when combined with Crisaborole. The risk or severity of adverse effects can be increased when Isoconazole is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Telaprevir. The risk or severity of adverse effects can be increased when Imatinib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Nicergoline is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Gabexate. The risk or severity of adverse effects can be increased when Ciprofloxacin is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Asunaprevir. The risk or severity of adverse effects can be increased when Dalfopristin is combined with Atorvastatin. Atorvastatin may increase the anticoagulant activities of Phenprocoumon. The risk or severity of adverse effects can be increased when Prednisolone is combined with Atorvastatin. The serum concentration of Metoprolol can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Vincristine is combined with Atorvastatin. The serum concentration of Edoxaban can be increased when it is combined with Atorvastatin. Atorvastatin may increase the hypoglycemic activities of Gliclazide. The risk or severity of adverse effects can be increased when Ezetimibe is combined with Atorvastatin. The serum concentration of Nintedanib can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Zucapsaicin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ziconotide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Salbutamol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Nilotinib is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Saquinavir. The risk or severity of adverse effects can be increased when Clozapine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Candoxatrilat. The risk or severity of adverse effects can be increased when Mequitazine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Atorvastatin is combined with Cimetidine. The serum concentration of Atorvastatin can be increased when it is combined with Teriflunomide. The serum concentration of Atorvastatin can be decreased when it is combined with Sodium bicarbonate. The serum concentration of Atorvastatin can be decreased when it is combined with Calcium Carbonate. The serum concentration of Atorvastatin can be increased when it is combined with Cobicistat. The serum concentration of Atorvastatin can be decreased when it is combined with Bismuth Subcitrate. The risk or severity of adverse effects can be increased when Lacidipine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Argatroban. The risk or severity of adverse effects can be increased when Modafinil is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Tetrahydropalmatine is combined with Atorvastatin. The metabolism of Atorvastatin can be increased when combined with Pentobarbital. The serum concentration of Diltiazem can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ticlopidine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Bivalirudin. The serum concentration of Atorvastatin can be increased when it is combined with Aprotinin. The serum concentration of Atorvastatin can be increased when it is combined with Geldanamycin. The risk or severity of adverse effects can be increased when Sirolimus is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Racecadotril. The risk or severity of adverse effects can be increased when Epinephrine is combined with Atorvastatin. The serum concentration of Mevastatin can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Josamycin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lomustine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Cyclophosphamide is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Magaldrate. The risk or severity of adverse effects can be increased when Astemizole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Kitasamycin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Prednisone is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Rilpivirine. The serum concentration of Atorvastatin can be decreased when it is combined with Cholestyramine. The risk or severity of adverse effects can be increased when Metronidazole is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Pinaverium is combined with Atorvastatin. The metabolism of Atorvastatin can be decreased when combined with Celecoxib. The serum concentration of Atorvastatin can be increased when it is combined with Zofenopril. The metabolism of Atorvastatin can be increased when combined with St. John's Wort. The risk or severity of adverse effects can be increased when Efinaconazole is combined with Atorvastatin. Atorvastatin may increase the anticoagulant activities of Ethyl biscoumacetate. The metabolism of Atorvastatin can be increased when combined with Rifampicin. The risk or severity of adverse effects can be increased when Histamine is combined with Atorvastatin. The serum concentration of Cilostazol can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Fosphenytoin. The risk or severity of adverse effects can be increased when Lomitapide is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Darexaban. The serum concentration of Atorvastatin can be increased when it is combined with Erythromycin. The risk or severity of adverse effects can be increased when Methysergide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Perhexiline is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Caffeine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Thiorphan. The serum concentration of Atorvastatin can be decreased when it is combined with Magnesium oxide. The risk or severity of adverse effects can be increased when Irbesartan is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Oxymetholone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Rutin is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Norfloxacin is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Itraconazole. The risk or severity of adverse effects can be increased when Fluvoxamine is combined with Atorvastatin. The serum concentration of Atorvastatin can be decreased when it is combined with Colestipol. The risk or severity of adverse effects can be increased when Isradipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Niacin is combined with Atorvastatin. Colchicine may increase the myopathic rhabdomyolysis activities of Atorvastatin. The risk or severity of adverse effects can be increased when Olanzapine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Doxycycline is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Batimastat. The serum concentration of Atorvastatin can be increased when it is combined with Fosinopril. The risk or severity of adverse effects can be increased when Manidipine is combined with Atorvastatin. The serum concentration of Prucalopride can be increased when it is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Lercanidipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Naftopidil is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Ranitidine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Sulfanilamide is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Regorafenib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Rolitetracycline is combined with Atorvastatin. The serum concentration of Ledipasvir can be increased when it is combined with Atorvastatin. The metabolism of Atorvastatin can be decreased when combined with Amiodarone. The metabolism of Atorvastatin can be increased when combined with Secobarbital. Raltegravir may increase the myopathic rhabdomyolysis activities of Atorvastatin. The risk or severity of adverse effects can be increased when Sulfinpyrazone is combined with Atorvastatin. Azithromycin may increase the myopathic rhabdomyolysis activities of Atorvastatin. The risk or severity of adverse effects can be increased when Diethylstilbestrol is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Phosphoramidon. The risk or severity of adverse effects can be increased when Nimodipine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Bromocriptine is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Diazepam is combined with Atorvastatin. The serum concentration of Ibrutinib can be increased when it is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Z-Val-Ala-Asp fluoromethyl ketone. The risk or severity of adverse effects can be increased when Eperisone is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Idelalisib is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Terfenadine is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline. The serum concentration of Atorvastatin can be increased when it is combined with Lepirudin. The risk or severity of adverse effects can be increased when Resveratrol is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Fosaprepitant is combined with Atorvastatin. The serum concentration of Atorvastatin can be increased when it is combined with Ecabet. The risk or severity of adverse effects can be increased when Metergoline is combined with Atorvastatin.